Bruce Rogers - "Discovery of N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an Agonist of the 7 Nicotinic Acetylcholine Receptor, for the Potential Treatment of Cognitive Deficits in Schizophrenia: Synthesis and Structure-Activi...

Version 1

      Publication Details (including relevant citation   information): "Discovery of   N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide,   an Agonist of the 7 Nicotinic Acetylcholine Receptor, for the   Potential Treatment of Cognitive Deficits in Schizophrenia:   Synthesis and Structure-Activity Relationship." Donn G. Wishka,   Daniel P. Walker, Karen M. Yates, Steven C. Reitz, Shaojuan Jia,   Jason K. Myers, Kirk L. Olson, E. Jon Jacobsen, Mark L. Wolfe,   Vincent E. Groppi, Alexander J. Hanchar, Bruce A. Thornburgh, Luz   A. Cortes-Burgos, Erik Wong, Brian A. Staton, Thomas J. Raub,   Nicole R. Higdon, Theron M. Wall, Raymond S. Hurst, Rodney R.   Walters, William E. Hoffmann, Mihaly Hajos, Stanley Franklin,   Galen Carey, Lisa H. Gold, Karen K. Cook, Steven B. Sands,   Sabrina X. Zhao, John R. Soglia, Amit S. Kalgutkar, Stephen P.   Arneric, Bruce N. Rogers* J. Med. Chem. 2006, 49, 4425-36.

      Abstract: null

      Address (URL):